GGrantIndex
Sort

30,917 grants matching tumor microenvironment

UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center

$730,000
Charles M Perou · Univ Of North Carolina Chapel Hill · UG1 · FY2019 · CA

Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M

$729,773
Anil K Rustgi · University Of Pennsylvania · P01 · FY2012 · CA

Hypoxia, tuberculosis, and T cell dysfunction

$729,692
Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · AI

Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy

$729,411
Lily Yang · Emory University · U01 · FY2016 · CA

(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity

$729,393
Dean W Felsher · Stanford University · R01 · FY2017 · CA

Small molecule enhancers of tumor immunity targeting the LPA5 GPCR

$729,283
Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA

The use of chitosan for cancer vaccine delivery

$729,049
John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Impact of Cellular and Extracellular Host Components on Tumor Progression

$729,039
Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2015 · CA

Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.

$728,983
Katerina Abigail Politi · Yale University · U01 · FY2023 · CA

Enhance UCSC Xena: extend interactive visualization to ultra-large-scale multi-omics data and integrate with analysis resources

$728,574
Jingchun Zhu · University Of California Santa Cruz · U24 · FY2024 · CA

Personalized Adoptive T-cell Therapy for AML

$728,501
David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA

Isolation, Propagation and Characterization of Breast Stem Cells

$728,442
Barbara Vonderhaar · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center

$728,371
Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2023 · CA

Engineered T cell approaches for Alzheimer's disease

$728,370
Jonathan Kipnis · Washington University · R61 · FY2025 · AG

UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center

$728,348
Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2021 · CA

Three-dimensional Scaffold-based Systems for Primary Human Intestinal Culture

$728,106
Calvin J Kuo · Stanford University · R01 · FY2010 · DK

Impact of Leukemia Microenvironment on Response to Targeted Therapies in AML

$727,832
Anupriya Agarwal · Oregon Health & Science University · U54 · FY2017 · CA

Biological determinants of colorectal cancer outcomes in Latinos of diverse ancestral origins

$727,816
Stephanie L. Schmit · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA

Cellular, molecular and quantitative imaging analysis of screening-detected lung adenocarcinoma

$727,581
Pierre P Massion · Vanderbilt University Medical Center · U01 · FY2017 · CA

Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer

$727,224
Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia

$727,057
Ling Li · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Microenvironmental regulation of glioblastoma radiosensitivity

$726,840
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Targeting novel therapeutic vulnerabilities in LKB1 mutant tumors.

$726,766
Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2018 · CA

Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M

$726,557
Anil K Rustgi · University Of Pennsylvania · P01 · FY2010 · CA

Leveraging fructose transport to create a privileged substrate to selectively fuel T cells

$726,151
Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA